[mo_oauth_login]
Summary report
IXOS PHARMA OÜ
Date of report 16.05.2025
IXOS PHARMA OÜ
16845293 -
Registered
Founded in
23.10.2023
Fixed capital
2,500 €
VAT
EE102669938
(start 24.10.2023)
| start | end |
|---|---|
| 24.10.2023 | - |
keywords
- muude toiduainete tootmine
IXOS PHARMA OÜ
Scores and ratings
Reputation score
60
What is Reputation score?
Credit Score
Risky
0.99
Credit score today
Risky
0.99
2023
year
Open the reports you want to print
Employees and salaries
IXOS PHARMA OÜ
Number of employees and estimated average salaries?
| 2024 II | 2024 III | 2024 IV | 2025 I | |
| Number of employees | ...... | ...... | ...... | ...... |
| Average gross salary | ...... | ...... | ...... | ...... |
IXOS PHARMA OÜ
Employee taxes and performance analysis?
| Quarter | Labor taxes paid | Number of employees | Turnover Per Employee | Profit per employee |
|---|---|---|---|---|
| 2025 I | ...... | ...... | ...... | ...... |
| 2024 IV | ...... | ...... | ...... | ...... |
| 2024 III | ...... | ...... | ...... | ...... |
| 2024 II | ...... | ...... | ...... | ...... |
| 2024 I | ...... | ...... | ...... | ...... |
| 2023 IV | ...... | ...... | ...... | ...... |
Deciders and beneficiaries
IXOS PHARMA OÜ
Decision-makers?
Relations:
3
Turnover 2025:
55 828 492 €
Employees:
11
Laura Saar
★★★★
......
Credit Score: Borderline
Reputation score: 14660
Date of birth: ......
Active relations 3
4 followers
*Every member of the management board may represent the private limited company in concluding all transactions.
IXOS PHARMA OÜ
History of right of representation?
Field
Manufactoring
Business age
1y
Beneficial country:
Estonia
Laura Saar
... - ...
2023
2024
2025
2023
2024
2025
IXOS PHARMA OÜ
Owners?
Former owners
| Name | Credit Score | Payment | Beginning | Type | Holding |
|---|---|---|---|---|---|
| ...... | ...... | ...... |
100%
|
Beneficiaries
Volumes and values of beneficiaries' assets
Net asset value of the beneficiary
... €
Value of beneficiary companies using the income method
... €
Analytically identified company holdings and asset volumes
Finances and assets
IXOS PHARMA OÜ
Goodwill| EUR | 2023 | 2024 | 2025 | Trend |
| Goodwill | ...... | ...... | ...... | |
| Goodwill | ...... | ...... | ...... |
IXOS PHARMA OÜ
Taxes paid and estimated average salaries| 2023 | 2024 | 2025 | |
| National taxes | ...... | ...... | ...... |
| Labor taxes | ...... | ...... | ...... |
| Average gross salary | ...... | ...... | ...... |
IXOS PHARMA OÜ
Quarterly indicators| Quarter | Turnover | Taxed turnover | Labour productivity | Labour productivity | Employees | National taxes | Labor taxes |
|---|---|---|---|---|---|---|---|
| 2025 I | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2024 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 IV | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
IXOS PHARMA OÜ
Sales revenue by country| Turnover EUR | 2023 prognosis | 2024 prognosis | 2025 prognosis | Trend |
| Total sales | ...... | ...... | ...... | |
| Estonia | ...... | ...... | ...... | |
| Total exports | ...... | ...... | ...... |
IXOS PHARMA OÜ
Financial indicators and prognosis| Financial indicators | 2023 Prognosis | 2024 Prognosis | 2025 Prognosis |
Trend |
| TURNOVER | ...... | ...... | ...... | |
| Estonia | ...... | ...... | ...... | |
| Other countries | ...... | ...... | ...... | |
| INTEREST INCOME | ...... | ...... | ...... | |
| OTHER BUSINESS INCOME | ...... | ...... | ...... | |
| TURNOVER IN RELATED COMPANY | ...... | ...... | ...... | |
| AVERAGE MONTHLY TURNOVER | ...... | ...... | ...... | |
| Available credit (credit limit) | ...... | ...... | ...... | |
| Settlement dates | ...... | ...... | ...... | |
| RECEIVED GRANTS € | ...... | ...... | ...... | |
| TENDERS WON € | ...... | ...... | ...... | |
| ASSETS | ...... | ...... | ...... | |
| Current assets | ...... | ...... | ...... | |
| Fixed assets | ...... | ...... | ...... | |
| LIABILITIES | ...... | ...... | ...... | |
| Short-term liabilities | ...... | ...... | ...... | |
| Long-term liabilities | ...... | ...... | ...... | |
| EQUITY | ...... | ...... | ...... | |
| Share-(equity capital) | ...... | ...... | ...... | |
| Retained profits | ...... | ...... | ...... | |
| Net profit | ...... | ...... | ...... | |
| NET WORKING CAPITAL | ...... | ...... | ...... | |
| NUMBER OF EMPLOYEES | ...... | ...... | ...... |
IXOS PHARMA OÜ
Financial raiting: "SATISFACTORY" (2025 prognosis)| Multipliers and income levels | 2024 prognosis | 2025 prognosis |
Trend |
| LIQUIDITY | ...... | ...... | |
| Net Working capital | ...... | ...... | |
| Short-term debt coverage ratio (X) | ...... | ...... | |
| EFFECTIVENESS | ...... | ...... | |
| Debt to assets ratio (X) | ...... | ...... | |
| Capitalisation multiplier (X) | ...... | ...... | |
| USE OF LOAN CAPITAL | ...... | ...... | |
| Turnover ratio of fixed assets (X) | ...... | ...... | |
| PROFITABILITY | ...... | ...... | |
| Sales revenues (%) | ...... | ...... | |
| Total asset revenues (%) | ...... | ...... | |
| Equity revenues (%) | ...... | ...... |
2025 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good
IXOS PHARMA OÜ
Annual reportsAnnual reports MISSING
Liabilities and debts
IXOS PHARMA OÜ
Credit score history and prognosisRecommended credit limit
... €
Recommended payment term
......
Business risk classes:
Trustworthy Neutral
Borderline
Problematic
Risky
IXOS PHARMA OÜ
Reports and assets-liabilities overview 16.05.2025?
Annual reports:
......
Annual reports: ......
Tax declarations: ......
......
......
......
......
......
......
Assets to cover liabilities (short-term)
Assets: ...... €1 EURO of assets to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €
IXOS PHARMA OÜ
Claims history?
1 month
6 months
Year
5 years
MAX
1 month
6 months
Year
5 years
MAX
Debt claims as of ......
Total debt claims: ...... €
PAYMENT SCHEDULE
......Latest events
| ...... | ...... |
IXOS PHARMA OÜ
Debt by type 16.05.2025?
| Type of claim | Amount of claims | In repayment schedule | Disputed | Management board during which the debt was incurred | Representative |
|---|---|---|---|---|---|
| Tax collector 's claims | ...... € | ...... € | ...... € | ||
| SUNNIRAHA | ...... € | ...... € | ...... € | ETCB | |
| Creditors' claims | ...... € | ...... € | ...... € | ||
| Total | ...... € | ...... € | ...... € |
IXOS PHARMA OÜ
Time-barred and ongoing claims as of 16.05.2025?
Ongoing
Sum:
Sum:
......
...... €
...... €
Time-barred
Sum:
Sum:
......
...... €
...... €
IXOS PHARMA OÜ
Income (turnover) and expenditure (taxes paid)?
| Quarter | Turnover | Taxed turnover | National taxes paid | Labor taxes paid | Number of employees |
|---|---|---|---|---|---|
| 2025 I | ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 IV | ...... € | ...... € | ...... € | ...... € | ...... |
IXOS PHARMA OÜ
Bailiff's enforcement proceedings as of 16.05.2025?
Bailiff's enforcement proceedings MISSING
IXOS PHARMA OÜ
Regulations of the Payment Order Department as of 16.05.2025?
Regulations of the Payment Order Department MISSING
IXOS PHARMA OÜ
Court orders in the register as of 16.05.2025?
Court order MISSING
IXOS PHARMA OÜ
Decisions of the Consumer Disputes Committee as of 16.05.2025?
Consumer disputes MISSING
IXOS PHARMA OÜ
Court hearings as of 16.05.2025?
Court hearings MISSING
IXOS PHARMA OÜ
Rulings as of 16.05.2025?
Court settlemets MISSING
IXOS PHARMA OÜ
Notices and announcements as of 16.05.2025?
Announcements MISSING
Marketing
Business network
IXOS PHARMA OÜ
Business networkCREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired
Sign in
To expand your connections, log in to the "Networks" environment
Beneficiaries network
IXOS PHARMA OÜ
Networks - Beneficiaries
The network is visible with reduced links
Expand threads if desired
Sign in
To expand your connections, log in to the "Networks" environment
Monitoring events
Filter
Dropdown
Dropdown
Neutral
Positive
Negative
11.05.2025
Credit class worsened
Previous credit class: Borderline
New credit class: Risky
25.04.2025
Credit class improved
Previous credit class: Problematic
New credit class: Borderline
23.04.2025
Credit class worsened
Previous credit class: Borderline
New credit class: Problematic
18.04.2025
Credit class improved
Previous credit class: Problematic
New credit class: Borderline
No monitoring events found.
Failed to load monitoring events.